What Privium Fund Management B.V. reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1795097 · Filed Aug 7, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 370K |
| −9.1% |
| $42.2M |
| 7.8% |
AMDAdvanced Micro Devices Inc | 62K | ±0% | $36M | 6.6% |
AMZNAmazon Com Inc | 140K | +12.0% | $33.4M | 6.1% |
IONSIonis Pharmaceuticals Inc | 319.9K | +10.3% | $25.4M | 4.7% |
SPOTSpotify Technology S.A. | 55K | −17.9% | $25.3M | 4.6% |
PLTRPalantir Technologies Inc. | 200K | ±0% | $23.3M | 4.3% |
ARWRArrowhead Pharmaceuticals, Inc. | 234.2K | −36.2% | $19.1M | 3.5% |
OPENOpendoor Technologies Inc. | 3.9M | New | $18.2M | 3.3% |
LMNDLemonade, Inc. | 270.3K | +5.9% | $17.6M | 3.2% |
NVDANVIDIA Corp | 81K | ±0% | $16.2M | 3% |
IRENIREN Ltd | 340.2K | +6.2% | $15.6M | 2.9% |
QUREuniQure N.V. | 328.3K | −32.5% | $15.1M | 2.8% |
CBRSCerebras Systems Inc. | 60.5K | New | $13.4M | 2.5% |
ASTSAST SpaceMobile, Inc. | 145K | ±0% | $12.9M | 2.4% |
RAREUltragenyx Pharmaceutical Inc. | 338.8K | −7.1% | $11.3M | 2.1% |
ARQTArcutis Biotherapeutics, Inc. | 399.4K | +24.4% | $10.5M | 1.9% |
BIIBBiogen Inc. | 48.4K | +10.5% | $10.5M | 1.9% |
PRQRProQR Therapeutics N.V. | 5.5M | +1.0% | $10.3M | 1.9% |
AXSMAxsome Therapeutics, Inc. | 39.9K | −32.0% | $9.8M | 1.8% |
URGNUroGen Pharma Ltd. | 210K | −11.8% | $7.7M | 1.4% |
SPCXSpace Exploration Technologies Corp | 40K | New | $6.8M | 1.3% |
DNLIDenali Therapeutics Inc. | 229.9K | −9.8% | $5.9M | 1.1% |
VRTXVertex Pharmaceuticals Inc | 9.4K | −17.2% | $4.7M | 0.9% |
BMRNBioMarin Pharmaceutical Inc | 75K | −18.7% | $4.3M | 0.8% |
KRYSKrystal Biotech, Inc. | 11.2K | ±0% | $4.2M | 0.8% |
ALNYAlnylam Pharmaceuticals, Inc. | 11.4K | −7.0% | $3.4M | 0.6% |
VRDNViridian Therapeutics, Inc. | 173.5K | ±0% | $3.2M | 0.6% |
BNTXBioNTech SE | 30.1K | +11.5% | $2.8M | 0.5% |
HIMSHims & Hers Health, Inc. | 80K | +100.0% | $2.8M | 0.5% |
MGTXMeiraGTx Holdings plc | 196.1K | −7.5% | $2.6M | 0.5% |
ABEVAmbev S.A. | 802.2K | −15.4% | $2.5M | 0.5% |
SRPTSarepta Therapeutics, Inc. | 136.5K | +196.7% | $2.5M | 0.5% |
CRSPCRISPR Therapeutics AG | 45K | +4.9% | $2.5M | 0.5% |
BEAMBeam Therapeutics Inc. | 70.3K | +9.8% | $2.4M | 0.4% |
ZLABZai Lab Ltd | 122.2K | −7.6% | $2.3M | 0.4% |
MRNAModerna, Inc. | 30K | ±0% | $2.1M | 0.4% |
RNACCartesian Therapeutics, Inc. | 151.7K | −15.3% | $1.6M | 0.3% |
MICCMagnum Ice Cream Co N.V. | 98.2K | New | $1.5M | 0.3% |
WVEWave Life Sciences, Inc. | 241K | ±0% | $1.4M | 0.3% |
TSHATaysha Gene Therapies, Inc. | 198.9K | +9.3% | $1.4M | 0.2% |
ZTSZoetis Inc. | 17.3K | New | $1.2M | 0.2% |
FDMT4D Molecular Therapeutics, Inc. | 90.1K | −47.1% | $1.2M | 0.2% |
FATEFate Therapeutics Inc | 414.3K | ±0% | $1.1M | 0.2% |
LEGNLegend Biotech Corp | 35.4K | New | $1M | 0.2% |
RCKTRocket Pharmaceuticals, Inc. | 244.1K | +0.8% | $835K | 0.2% |
NOVNOV Inc. | 42K | ±0% | $779.6K | 0.1% |
BTGB2GOLD Corp | 195.1K | +102.2% | $729.6K | 0.1% |
TTETotalEnergies SE | 10.7K | New | $729.5K | 0.1% |
LXEOLexeo Therapeutics, Inc. | 155K | −24.4% | $722.3K | 0.1% |
RIGTransocean Ltd. | 145.6K | +36.6% | $712K | 0.1% |
MOHMolina Healthcare, Inc. | 3K | −63.4% | $681.3K | 0.1% |
NUNu Holdings Ltd. | 44K | New | $587.8K | 0.1% |
AUTLAutolus Therapeutics plc | 363.4K | ±0% | $581.5K | 0.1% |
TDWTidewater Inc | 8.7K | +58.4% | $578.5K | 0.1% |
LULUlululemon athletica inc. | 5.1K | New | $578.1K | 0.1% |
SDSandridge Energy Inc | 38.8K | ±0% | $531.5K | 0.1% |
SASeabridge Gold Inc | 16.5K | New | $425K | 0.1% |
VYGRVoyager Therapeutics, Inc. | 120K | ±0% | $420K | 0.1% |
ENGNenGene Therapeutics Inc. | 170K | New | $294.1K | 0.1% |
CSANCosan S.A. | 52K | New | $149.8K | 0.1% |
